THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1

被引：314
|
作者：
COLOTTA, F
DOWER, SK
SIMS, JE
MANTOVANI, A
机构：
[1] UNIV BRESCIA,DEPT BIOTECHNOL,PATHOL SECT,I-25123 BRESCIA,ITALY
[2] IMMUNEX RES & DEV CORP,SEATTLE,WA 98101
来源：
IMMUNOLOGY TODAY | 1994年 / 15卷 / 12期
关键词：
D O I：
10.1016/0167-5699(94)90217-8
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The interleukin 1 (IL-1) system plays a central role in inflammation and immunity. Of the two receptors that bind IL-1, the type I receptor is known to mediate signaling activity: whereas the function of the type II receptor remains unknown. Here, Francesco Colotta and colleagues review the properties of these receptors and summarize evidence indicating that the type II receptor acts as a regulated decoy target for IL-1.
引用
收藏
页码：562 / 566
页数：5
相关论文
共 50 条
  • [1] THE TYPE-II RECEPTOR AS A DECOY TARGET FOR INTERLEUKIN-1
    RE, F
    COLOTTA, F
    MUZIO, M
    POLENTARUTTI, N
    SIMS, JE
    DOWER, SK
    GIRI, JG
    MANTOVANI, A
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, : 51 - 51
  • [2] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    CLARK, BD
    MANCILLA, J
    DINARELLO, CA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (22) : 14147 - 14150
  • [3] INTERLEUKIN-1 RECEPTOR ANTAGONIST COMPETITIVELY INHIBITS THE BINDING OF INTERLEUKIN-1 TO THE TYPE-II INTERLEUKIN-1 RECEPTOR
    GRANOWITZ, EV
    MANCILLA, J
    CLARK, BD
    DINARELLO, CA
    CLINICAL RESEARCH, 1991, 39 (02): : A462 - A462
  • [4] CHEMOATTRACTANTS INDUCE RAPID RELEASE OF THE INTERLEUKIN-1 TYPE-II DECOY RECEPTOR IN HUMAN POLYMORPHONUCLEAR CELLS
    COLOTTA, F
    ORLANDO, S
    FADLON, EJ
    SOZZANI, S
    MATTEUCCI, C
    MANTOVANI, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06): : 2181 - 2188
  • [5] INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4
    COLOTTA, F
    RE, F
    MUZIO, M
    BERTINI, R
    POLENTARUTTI, N
    SIRONI, M
    GIRI, JG
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    SCIENCE, 1993, 261 (5120) : 472 - 475
  • [6] TRANSFECTED TYPE-II INTERLEUKIN-1 RECEPTOR IMPAIRS RESPONSIVENESS OF HUMAN KERATINOCYTES TO INTERLEUKIN-1
    BOSSU, P
    VISCONTI, U
    RUGGIERO, P
    MACCHIA, G
    MUDA, M
    BERTINI, R
    BIZZARRI, C
    COLAGRANDE, A
    SABBATINI, V
    MAURIZI, G
    DELGROSSO, E
    TAGLIABUE, A
    BORASCHI, D
    AMERICAN JOURNAL OF PATHOLOGY, 1995, 147 (06): : 1852 - 1861
  • [7] Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis
    Akoum, A
    Jolicoeur, C
    Kharfi, A
    Aubé, M
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (02): : 481 - 489
  • [8] THE TYPE-II RECEPTOR AS A DECOY TARGET FOR INTERLEUKIN-1 IN POLYMORPHONUCLEAR LEUKOCYTES - CHARACTERIZATION OF INDUCTION BY DEXAMETHASONE AND LIGAND-BINDING PROPERTIES OF THE RELEASED DECOY RECEPTOR
    RE, F
    MUZIO, M
    DEROSSI, M
    POLENTARUTTI, N
    GIRI, JG
    MANTOVANI, A
    COLOTTA, F
    JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02): : 739 - 743
  • [9] INTERLEUKIN-1 RECEPTOR ANTAGONIST BINDS TO THE TYPE-II INTERLEUKIN-1 RECEPTOR ON B-CELLS AND NEUTROPHILS
    DRIPPS, DJ
    VERDERBER, E
    NG, RK
    THOMPSON, RC
    EISENBERG, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (30) : 20311 - 20315
  • [10] THE INHIBITORY ACTIVITY OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IS ENHANCED BY TYPE-II INTERLEUKIN-1 SOLUBLE RECEPTOR AND HINDERED BY TYPE-I INTERLEUKIN-1 SOLUBLE RECEPTOR
    BURGER, D
    CHICHEPORTICHE, R
    GIRI, JG
    DAYER, JM
    JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01): : 38 - 41
12345